SBIR/STTR Research Award
Multiplexed Diagnostic Platform for Invasive Fungal Infection
Award amount
$249,999Program and phase
SBIR · Phase IAward year
2024Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- EMERGINGDX INC
- Proposal award date
- 2024-02-02
- Contract end date
- 2024-09-04
- UEI
- C1LMYC2AY934
- Solicitation number
- 23.3
- Topic code
- DHA233-001
Research abstract
EmergingDx in collaboration with its partners will develop a novel rapid diagnostic platform for invasive fungal infection. The core technology involves a self-contained multiplexed microfluidic cartridge with very sensitive sensors and a reader that can detect and speciate invasive fungal wound infections from a biomatrix.Ā
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Autonomous Soft Robot for Locomotion in Granular Seabed Media
- Rapid, Automated, Multiplexed Omics Platform
- Integrated Multiplexed Low-Cost Diagnostic Platform for Rapid Microbial Identification
- Multiplexed Diagnostic Platform for Invasive Fungal Infection
- Rapid, Automated, Multiplexed Omics Platform
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
12 SBIR/STTR records share this UEI (2023–2025). Reported award amounts total $6,696,877. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Agriculture